Protein vaccination with HPV16 E7/Pep-1 nanoparticles elicits a protective T-helper cell-mediated immune response.

about

Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines.

P2860

Q52672798-800290E5-5F8C-45F4-8894-A73605FD60B8

P2860

Protein vaccination with HPV16 E7/Pep-1 nanoparticles elicits a protective T-helper cell-mediated immune response.

Item

http://www.wikidata.org/entity/Q38777042

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Protein vaccination with HPV16 ...... cell-mediated immune response.

@en

type

Item

label

Protein vaccination with HPV16 ...... cell-mediated immune response.

@en

prefLabel

Protein vaccination with HPV16 ...... cell-mediated immune response.

@en

P1476

Protein vaccination with HPV16 ...... cell-mediated immune response

@en

P2093

Elnaz Agi

http://www.w3.org/2001/XMLSchema#string

Golnaz Mardani

http://www.w3.org/2001/XMLSchema#string

Sepideh Shahbazi

http://www.w3.org/2001/XMLSchema#string

Seyed Mehdi Sadat

http://www.w3.org/2001/XMLSchema#string

P2860

Preferentially localized dynein and perinuclear dynactin associate with nuclear pore complex proteins to mediate genomic union during mammalian fertilization

Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade

Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants

Interactions of amphipathic carrier peptides with membrane components in relation with their ability to deliver therapeutics.

In vivo protein transduction: biologically active intact pep-1-superoxide dismutase fusion protein efficiently protects against ischemic insult.

In vivo protein transduction: delivery of PEP-1-SOD1 fusion protein into myocardium efficiently protects against ischemic insult.

Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses.

Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments

Immunotherapy for cervical cancer: Research status and clinical potential

Prevalence, genotype distribution and persistence of human papillomavirus in oral mucosa of women: a six-year follow-up study.

P304

459-467

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IUB.1503

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Azam Bolhassani

P577

2016-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27094221

http://www.w3.org/2001/XMLSchema#string

Protein vaccination with HPV16 E7/Pep-1 nanoparticles elicits a protective T-helper cell-mediated immune response.

about

P2860

P2860

Protein vaccination with HPV16 E7/Pep-1 nanoparticles elicits a protective T-helper cell-mediated immune response.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698